The authors created a chimeric antigen-receptor (CAR) that was capable of on-demand downregulation by fusing the CAR to a previously developed ligand-induced degradation domain. Addition of a small molecule ligand triggered exposure of a cryptic degron within the ligand-induced degradation domain (LID), resulting in proteasomal degradation of the CAR-LID fusion protein and loss of CAR on the surface of T cells.
[Molecular Therapy]
6445212 {6445212:NS3S6YGZ} items 1 apa 0 default asc 1 150766 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/ %7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-467cc322a885b0eac7199c26dada380f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22NS3S6YGZ%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%202em%3B%20text-indent%3A-2em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELigand-induced%20degradation%20of%20a%20CAR%20permits%20reversible%20remote%20control%20of%20CAR%20T%20cell%20activity%20in%20vitro%20and%20in%20vivo%3A%20Molecular%20Therapy.%20%28n.d.%29.%20Retrieved%20June%2016%2C%202020%2C%20from%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fmolecular-therapy-family%5C%2Fmolecular-therapy%5C%2Ffulltext%5C%2FS1525-0016%2820%2930294-X%27%3Ehttps%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fmolecular-therapy-family%5C%2Fmolecular-therapy%5C%2Ffulltext%5C%2FS1525-0016%2820%2930294-X%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DNS3S6YGZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Ligand-induced%20degradation%20of%20a%20CAR%20permits%20reversible%20remote%20control%20of%20CAR%20T%20cell%20activity%20in%20vitro%20and%20in%20vivo%3A%20Molecular%20Therapy%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fmolecular-therapy-family%5C%2Fmolecular-therapy%5C%2Ffulltext%5C%2FS1525-0016%2820%2930294-X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-16T15%3A57%3A02Z%22%7D%7D%5D%7DLigand-induced degradation of a CAR permits reversible remote control of CAR T cell activity in vitro and in vivo: Molecular Therapy. (n.d.). Retrieved June 16, 2020, from
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(20)30294-X Cite